⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77750 | 1.00 | — | — | |
| SCHEMBL77751 | 1.00 | — | — | |
| SCHEMBL6470508 | 0.97 | — | — | |
| SCHEMBL3320474 | 0.79 | — | — | |
| SCHEMBL3320478 | 0.79 | — | — | |
| SCHEMBL14050302 | 0.78 | TGFBR1 (0.60) | — | |
| SCHEMBL27637802 | 0.78 | TGFBR1 (0.60) | — | |
| SCHEMBL21950137 | 0.78 | TGFBR1 (0.60) | — | |
| SCHEMBL8575470 | 0.77 | TGFBR1 (0.58) | — | |
| SCHEMBL8212102 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1231213-B1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI (IT) | 2004-08-11 | — | — | EP | claimed |
| US-6635456-B2 | Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide | FIDIA FARMACEUTICI S.P.A. (IT) | 2003-10-21 | — | — | US | claimed |
| US-20020155558-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-10-24 | — | — | US | claimed |
| WO-2002064603-A1 | PROCEDURE FOR THE PREPARATION OF PURE PHOSPHATIDES AND THEIR USE IN THE COSMETIC, PHARMACEUTICAL AND ALIMENTARY FIELDS | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-08-22 | — | — | WO | claimed |
| EP-1231213-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.p.A. (IT) | 2002-08-14 | — | — | EP | claimed |
| CN-117098541-A | Lipid nanoparticles for delivery of nucleic acids and related methods of use | 阿卡格拉医药公司 | 2023-11-21 | — | — | CN | disclosed |
| EP-2918262-B1 | Induction of antigen-specific tolerance by peripheral phagocytosis | PLS DESIGN GMBH (DE) | 2023-08-09 | — | — | EP | disclosed |
| US-11065330-B2 | Induction of antigen-specific tolerance by peripheral phagocytosis | PLS-DESIGN GMBH (DE) | 2021-07-20 | — | — | US | disclosed |
| US-11001865-B2 | Modified lecithin, preparation thereof, and use as an antioxidant | THE UNIVERSITY OF MASSACHUSETTS (US) | 2021-05-11 | — | — | US | disclosed |
| EP-3787670-A1 | INDUCTION OF ALLERGEN-SPECIFIC TREGS PRIOR TO ORAL OR SUBLINGUAL IMMUNOTHERAPY OF FOOD ALLERGY | Luxembourg Institute of Health (LIH) (LU) | 2021-03-10 | — | — | EP | disclosed |
| EP-3723863-A1 | HYDROGEL-EMBEDDED OLIGODEOXYNUCLEOTIDES AS TOLEROGENIC ADJUVANT FOR SUBCUTANEOUS IMMUNOTHERAPY | Luxembourg Institute of Health (LIH) (LU) | 2020-10-21 | — | — | EP | disclosed |
| WO-2019076478-A1 | HYDROGEL-EMBEDDED OLIGODEOXYNUCLEOTIDES AS TOLEROGENIC ADJUVANT FOR SUBCUTANEOUS IMMUNOTHERAPY | LUXEMBOURG INSTITUTE OF HEALTH (LIH) (LU) | 2019-04-25 | — | — | WO | disclosed |
| EP-1231213-B1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI (IT) | 2004-08-11 | — | — | EP | disclosed |
| WO-2004037851-A2 | COLOSTRININ AND PEPTIDES THEREOF AS MODULATORS OF INTRACELLULAR SIGNALING MOLECULES AND INHIBITORS OF APOPTOSIS | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-05-06 | — | — | WO | disclosed |
| US-20040053376-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.P.A. | 2004-03-18 | — | — | US | disclosed |
| US-6635456-B2 | Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide | FIDIA FARMACEUTICI S.P.A. (IT) | 2003-10-21 | — | — | US | disclosed |
| EP-0819760-B1 | PROCESS FOR PRODUCING PHOSPHATIDYLSERINES HAVING POLYBASIC UNSATURATED FATTY ACID AS SIDE CHAIN | YAKULT HONSHA KK (JP) | 2003-02-05 | — | — | EP | disclosed |
| US-20020155558-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-10-24 | — | — | US | disclosed |
| WO-2002064603-A1 | PROCEDURE FOR THE PREPARATION OF PURE PHOSPHATIDES AND THEIR USE IN THE COSMETIC, PHARMACEUTICAL AND ALIMENTARY FIELDS | FIDIA FARMACEUTICI S.P.A. (IT) | 2002-08-22 | — | — | WO | disclosed |
| EP-1231213-A1 | Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields | FIDIA FARMACEUTICI S.p.A. (IT) | 2002-08-14 | — | — | EP | disclosed |